BioCentury
ARTICLE | Company News

Sosei, AstraZeneca milestone payment

April 7, 2017 7:43 PM UTC

Sosei’s Heptares Therapeutics subsidiary will receive a $12 million milestone payment from AstraZeneca under a 2015 deal granting AZ exclusive, worldwide rights to develop and commercialize AZD4635 (see BioCentury, Aug. 10, 2015). ...